Physician
Unity Healthcare
Unity Healthcare was paid $12.67M by Medicaid between Jan 2018 and Dec 2024, across 139 billing codes. Its largest line is 99284, emergency room visit (serious) — 38% of everything it billed.
33Billing provider infoUNITY HEALTHCARE
MUSCATINE, IA 52761
MUSCATINE, IA 52761
33aNPI1861444333assigned 05/16/2006
33bProvider typeAnesthesiology Physician
28Total paid$12.67M
24GClaims249,481
24DCodes billed139
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anesthesiology Physician providers in Iowa
Rank by total paid#1 of 15
Median peer was paid$11K
This provider vs. median1,144×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 41,243 | $2.17M | |
| 2019 | 39,773 | $2.04M | |
| 2020 | 31,769 | $1.72M | |
| 2021 | 41,738 | $2.24M | |
| 2022 | 40,702 | $2.05M | |
| 2023 | 37,986 | $1.69M | |
| 2024incomplete | 16,270 | $758K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 38% | 31,220 | 21,827 | $4.83M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 27% | 29,784 | 19,370 | $3.37M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 16% | 9,207 | 6,434 | $1.97M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 3.7% | 42,522 | 40,310 | $469K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.0% | 3,059 | 2,965 | $248K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.7% | 1,599 | 1,490 | $214K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 11,264 | 10,989 | $145K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,235 | 1,101 | $101K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 972 | 927 | $99K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,552 | 2,428 | $85K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,399 | 1,314 | $82K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,551 | 2,427 | $82K |
127 more codes
| 36415 | Collection of venous blood by venipuncture | <1% | 25,814 | $64K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 188 | $61K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 524 | $53K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 833 | $52K |
| 59025 | Fetal non-stress test | <1% | 402 | $50K |
| 87428 | <1% | 1,889 | $50K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 6,817 | $49K |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 90 | $47K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,024 | $44K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 515 | $31K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,732 | $29K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 288 | $28K |
| 87081 | <1% | 4,561 | $28K | |
| 80053 | Comprehensive metabolic panel | <1% | 12,142 | $23K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 169 | $22K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 27 | $22K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 2,535 | $18K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,570 | $17K |
| 80061 | Lipid panel | <1% | 1,491 | $16K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,440 | $16K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 131 | $16K |
| 71045 | Radiologic examination, chest; single view | <1% | 280 | $16K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 108 | $15K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 378 | $13K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 576 | $13K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 701 | $13K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 659 | $12K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 15,445 | $12K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 305 | $9K |
| 86900 | <1% | 144 | $9K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 23 | $6K |
| 87480 | <1% | 296 | $6K | |
| 87510 | <1% | 296 | $6K | |
| 87660 | <1% | 296 | $6K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 172 | $6K |
| 83655 | <1% | 550 | $6K | |
| D0190 | <1% | 334 | $5K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 234 | $5K |
| D1351 | Sealant - per tooth | <1% | 250 | $5K |
| D1206 | Topical application of fluoride varnish | <1% | 346 | $5K |
| 88142 | <1% | 231 | $4K | |
| 87807 | <1% | 410 | $4K | |
| 87210 | <1% | 573 | $4K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 164 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 705 | $4K |
| 87449 | <1% | 840 | $4K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 280 | $3K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 29 | $3K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 14 | $3K |
| 81002 | <1% | 1,054 | $3K | |
| 87088 | <1% | 552 | $3K | |
| 76830 | Ultrasound, transvaginal | <1% | 25 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 433 | $3K |
| 84439 | <1% | 389 | $3K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,172 | $2K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 122 | $2K |
| 85027 | <1% | 508 | $2K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 59 | $2K |
| 87340 | <1% | 192 | $1K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 57 | $1K |
| 82607 | <1% | 126 | $1K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 15 | $1K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 12 | $1K |
| 83735 | <1% | 1,060 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,100 | $986.99 |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 12 | $975.92 |
| 74018 | <1% | 13 | $937.37 | |
| 85018 | <1% | 390 | $890.00 | |
| 86762 | <1% | 92 | $791.81 | |
| 87653 | <1% | 32 | $782.04 | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 12 | $762.31 |
| 86593 | <1% | 159 | $648.24 | |
| J2704 | Injection, propofol, 10 mg | <1% | 600 | $644.18 |
| 82728 | <1% | 62 | $629.11 | |
| 86803 | <1% | 50 | $603.63 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 949 | $585.29 |
| 0240U | <1% | 15 | $570.52 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 650 | $565.64 |
| 80306 | <1% | 527 | $535.21 | |
| D1330 | <1% | 31 | $509.02 | |
| 84702 | <1% | 49 | $485.46 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 279 | $433.42 |
| 82746 | <1% | 42 | $403.11 | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 12 | $403.02 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 557 | $399.27 |
| 86780 | <1% | 43 | $376.26 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 314 | $362.07 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 172 | $354.83 |
| 86703 | <1% | 42 | $351.99 | |
| 87102 | <1% | 26 | $341.10 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 251 | $292.14 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 140 | $280.90 |
| D0602 | <1% | 206 | $197.15 | |
| 82950 | <1% | 44 | $185.33 | |
| 83550 | <1% | 26 | $132.80 | |
| 81001 | <1% | 1,710 | $109.44 | |
| 87147 | <1% | 24 | $108.24 | |
| 83540 | <1% | 26 | $98.40 | |
| 81025 | <1% | 14 | $81.80 | |
| 82565 | <1% | 16 | $66.11 | |
| D0603 | <1% | 45 | $42.00 | |
| 84703 | <1% | 864 | $21.38 | |
| 83690 | <1% | 1,464 | $14.51 | |
| 85730 | <1% | 79 | $13.34 | |
| 81003 | <1% | 874 | $12.71 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 121 | $8.02 |
| 85610 | <1% | 137 | $4.37 | |
| 84484 | <1% | 824 | $4.28 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 14 | $1.98 |
| 82077 | 0% | 117 | $0.00 | |
| 86901 | 0% | 144 | $0.00 | |
| 83605 | 0% | 498 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 889 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 40 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 28 | $0.00 |
| 86850 | 0% | 144 | $0.00 | |
| 83880 | 0% | 16 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 94 | $0.00 |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 0% | 16 | $0.00 |
| 86140 | 0% | 51 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 22 | $0.00 |
| 36416 | 0% | 24 | $0.00 | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 0% | 109 | $0.00 |
| 80179 | 0% | 16 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 158 | $0.00 |
| 80143 | 0% | 17 | $0.00 | |
| 80076 | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMORROW, SHAWN (PRESIDENT)
Parent organizationTRINITY REGIONAL HEALTH SYSTEM
| Provider | Location | Paid |
|---|---|---|
| Unity Healthcare | Muscatine, IA | $8.70M |
| Trinity Medical Center | Bettendorf, IA | $5.23M |
| Unity Healthcare | Muscatine, IA | $5.14M |
| Unity Healthcare | Muscatine, IA | $3.79M |
| Unity Healthcare | Muscatine, IA | $3.78M |
| Trinity Medical Center | Rock Island, IL | $2.67M |
| Unity Healthcare | Wilton, IA | $1.57M |
| Unity Healthcare | Muscatine, IA | $155K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.